| __timestamp | Insmed Incorporated | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56292000 | 21226345 |
| Thursday, January 1, 2015 | 74277000 | 87718074 |
| Friday, January 1, 2016 | 122721000 | 93831530 |
| Sunday, January 1, 2017 | 109749000 | 79419009 |
| Monday, January 1, 2018 | 145283000 | 132166913 |
| Tuesday, January 1, 2019 | 131711000 | 89124838 |
| Wednesday, January 1, 2020 | 181157000 | 65782137 |
| Friday, January 1, 2021 | 272744000 | 88845513 |
| Saturday, January 1, 2022 | 397518000 | 134715000 |
| Sunday, January 1, 2023 | 571011000 | 180142000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Insmed Incorporated and Intra-Cellular Therapies, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Insmed's R&D expenses surged by over 900%, peaking in 2023. This aggressive investment reflects their strategic focus on expanding their therapeutic pipeline. In contrast, Intra-Cellular Therapies, Inc. maintained a steady growth in R&D spending, with a notable 750% increase over the same period. This consistent investment underscores their commitment to developing groundbreaking treatments. As of 2023, Insmed's R&D expenses were more than three times that of Intra-Cellular Therapies, highlighting their divergent approaches. These trends offer valuable insights into the strategic priorities of these biotech leaders, shaping the future of medical innovation.
Comparing Innovation Spending: AbbVie Inc. and Intra-Cellular Therapies, Inc.
Research and Development: Comparing Key Metrics for Amgen Inc. and Intra-Cellular Therapies, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Genmab A/S and Insmed Incorporated
R&D Spending Showdown: Viatris Inc. vs Intra-Cellular Therapies, Inc.
Research and Development: Comparing Key Metrics for Intra-Cellular Therapies, Inc. and Halozyme Therapeutics, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Ligand Pharmaceuticals Incorporated
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amphastar Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Insmed Incorporated and Amneal Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Insmed Incorporated and Protagonist Therapeutics, Inc.
R&D Insights: How Insmed Incorporated and Wave Life Sciences Ltd. Allocate Funds
Research and Development Expenses Breakdown: Insmed Incorporated vs Mesoblast Limited